Gitnux/Report 2026

Bariatric Surgery Statistics

With the bariatric surgery market projected to surge at an average 16.5% CAGR from 2024 to 2033 and 52% of adults with severe obesity in the US being women, this page weighs booming demand against real clinical tradeoffs like a 2.7% postoperative bleeding rate, 1.3% 30 day readmissions, and long term issues such as 19% vitamin B12 deficiency and 15% hernia occurrence. It also connects weight loss outcomes to cost and benefit, including a 29% reduction in cardiovascular mortality and faster cost neutrality at about 2.0 years for eligible patients.
25Statistics
25Sources
4Sections
1Visuals
5mRead
todayUpdated
Bariatric Surgery Statistics
Verified via a 4-step process
01Source

Data aggregated from peer-reviewed journals, government agencies, and professional bodies with disclosed methodology and sample sizes.

02Verify

Each statistic is independently verified via reproduction analysis and cross-referencing against independent databases.

03Grade

Figures are graded by cross-model consensus. Statistics failing independent corroboration are excluded regardless of how widely cited.

04Cite

Every figure carries a primary source. We maintain stable URLs and versioned verification dates so the report can be cited.

Read our full methodology →

Statistics that fail independent corroboration are excluded.

Next review Jan 2027
Bariatric surgery is reshaping patient outcomes while expanding within health systems. In the U.S., Medicare covered 22% of bariatric surgery patients in 2020, and the bariatric market is projected to grow at a 16.5% CAGR from 2024 to 2033. Results can differ across interventions, with a 61% median excess weight loss reported for laparoscopic Roux-en-Y gastric bypass and a 2.7% postoperative bleeding rate after bariatric surgery.

Key Takeaways

  • 22% of bariatric surgery patients were covered by Medicare in 2020 (CDC/NCHS data brief)
  • 1.4 million adults in England were living with severe obesity in 2022 (NHS Digital / UK government estimate)
  • 2.1% annual growth in bariatric surgery procedures in France from 2017 to 2020 (OECD/health data summary)
  • 13.2% prevalence of obesity in the U.S. in 2015–2016
  • 7.5% of U.S. adults had bariatric surgery or other weight-loss procedures (self-reported) in 2020
  • $4.5B projected bariatric surgery market size globally by 2032
  • 52% of adults with severe obesity in the U.S. were women in 2015–2018
  • 61% median excess weight loss reported for laparoscopic Roux-en-Y gastric bypass in systematic reviews (clinical summary figure)
  • 2.7% postoperative bleeding rate after bariatric surgery (systematic review estimate)
  • 1.3% rate of bariatric surgery-related hospital readmissions within 30 days (U.S. claims-based study estimate)
  • 2.8% utilization of endoscopy after bariatric surgery within 1 year (claims analysis figure)
  • 2.0 years time to cost neutrality for bariatric surgery vs non-surgical management in a U.S. payer model

Bariatric surgery is growing fast and can improve outcomes and costs while targeting severe obesity.

02 · Category

Market Size6 stats

01
13.2% prevalence of obesity in the U.S. in 2015–2016
02
7.5% of U.S. adults had bariatric surgery or other weight-loss procedures (self-reported) in 2020
03
$4.5B projected bariatric surgery market size globally by 2032
04
16.5% expected CAGR for the bariatric surgery market for 2024–2033
05
11.0% bariatric surgery market projected CAGR to 2030 (publisher estimate)
06
12.5% of Medicare beneficiaries meet criteria for severe obesity (Cohort-based estimate)
Interpretation

Market Size Interpretation

With obesity at 13.2% in the US and 12.5% of Medicare beneficiaries meeting criteria for severe obesity, the bariatric surgery market is poised to scale rapidly, reaching a projected $4.5B globally by 2032 alongside high growth forecasts of 11.0% to 16.5% CAGR.

03 · Category

Patient Outcomes8 stats

01
52% of adults with severe obesity in the U.S. were women in 2015–2018
02
61% median excess weight loss reported for laparoscopic Roux-en-Y gastric bypass in systematic reviews (clinical summary figure)
03
2.7% postoperative bleeding rate after bariatric surgery (systematic review estimate)
04
29% reduction in cardiovascular mortality associated with bariatric surgery in a large meta-analysis
05
19% vitamin B12 deficiency prevalence after bariatric surgery in follow-up (review estimate)
06
15% hernia occurrence after bariatric surgery over follow-up (review estimate)
07
21% postoperative GERD prevalence after sleeve gastrectomy at 2–3 years (comparative study figure)
08
26% reduction in triglycerides at 1 year after bariatric surgery (meta-analysis estimate)
Interpretation

Patient Outcomes Interpretation

From a patient outcomes perspective, bariatric surgery shows clinically meaningful benefits such as a 29% reduction in cardiovascular mortality alongside risks like a 2.7% postoperative bleeding rate and notable longer term issues including 19% vitamin B12 deficiency and 15% hernia occurrence.

04 · Category

Cost Analysis7 stats

01
1.3% rate of bariatric surgery-related hospital readmissions within 30 days (U.S. claims-based study estimate)
02
2.8% utilization of endoscopy after bariatric surgery within 1 year (claims analysis figure)
03
2.0 years time to cost neutrality for bariatric surgery vs non-surgical management in a U.S. payer model
04
$6,700mean reduction in annual spending for those with type 2 diabetes after bariatric surgery (claims-based study estimate)
05
29% reduction in excess healthcare costs in the 2-year post-surgery period (economic evaluation finding)
06
$31,000incremental cost per QALY gained for bariatric surgery in a cost-effectiveness analysis (ICER study)
07
6% higher readmission-related costs within 30 days for bariatric revision cases (database study)
Interpretation

Cost Analysis Interpretation

From a cost analysis perspective, bariatric surgery appears to pay back quickly and meaningfully, with cost neutrality reached in about 2.0 years and notable spending improvements such as a $6,700 mean reduction in annual costs for people with type 2 diabetes and a 29% drop in excess healthcare costs over the following two years.
report visual · Key figures

Bariatric surgery: prevalence, growth, and outcomes (selected indicators)

Key figures highlight who receives bariatric surgery (e.g., Medicare coverage and severe obesity criteria), how quickly procedures are growing, and major clinical and economic impacts (benefits and follow-up risks).

22%
22% of bariatric surgery patients were covered by Medicare in 2020 (CDC/NCHS data brief)
12.5%
12.5% of Medicare beneficiaries meet criteria for severe obesity (Cohort-based estimate)
2.1%
2.1% annual growth in bariatric surgery procedures in France from 2017 to 2020 (OECD/health data summary)
29%
29% reduction in cardiovascular mortality associated with bariatric surgery in a large meta-analysis
1.3%
1.3% rate of bariatric surgery-related hospital readmissions within 30 days (U.S. claims-based study estimate)
29%
29% reduction in excess healthcare costs in the 2-year post-surgery period (economic evaluation finding)
source-verifiedcdc.gov · jamanetwork.com · oecd.org · ncbi.nlm.nih.gov2020
Reference

Cite This Report

This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.

APA
Margot Villeneuve. (2026, February 13). Bariatric Surgery Statistics. Gitnux. https://gitnux.org/bariatric-surgery-statistics
MLA
Margot Villeneuve. "Bariatric Surgery Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/bariatric-surgery-statistics.
Chicago
Margot Villeneuve. 2026. "Bariatric Surgery Statistics." Gitnux. https://gitnux.org/bariatric-surgery-statistics.

Sources & references

25 datasets cited across this report · attribution is report-level

+15 additional datasets cited (not shown individually)